Loading organizations...
Loading organizations...
Developing disruptive therapies in oncology and immuno-oncology.
PineTree Therapeutics has raised $87.5M across 3 funding rounds.
PineTree Therapeutics has raised $87.5M in total across 3 funding rounds.
PineTree Therapeutics has raised $87.5M in total across 3 funding rounds.
PineTree Therapeutics's investors include Atinum Investment, Yohan Kim, Gauss Capital Management, Korea Investment Partners, Samho Green Investment, SJ Investment Partners, Smilegate Investment, S&S Investment, STIC Ventures, SV Investment, Widwin Investment, STIC Investments.
PineTree Therapeutics has raised $87.5M across 3 funding rounds. Most recently, it raised $47.0M Series B in October 2025.
| Date | Round | Lead Investors | Other Investors |
|---|---|---|---|
| Oct 28, 2025 | $47.0M Series B | Atinum Investment, Yohan Kim, Gauss Capital Management, Korea Investment Partners, Samho Green Investment, SJ Investment Partners, Smilegate Investment, S&S Investment, STIC Ventures, SV Investment, Widwin Investment | |
| Jul 30, 2024 | $17.0M Series A | Yohan Kim, STIC Investments | Atinum Investment, Quantum FA, Schmidt, SGI Partners, S&S Investment |
| Jun 8, 2022 | $23.5M Series A | DSC Investment, InterVest, J Curve Investment, Samho Green Investment, SJ Investment Partners, SK Securities |